ScoreWhy is Indo US Bio-Tech Ltd ?
1
High Management Efficiency with a high ROCE of 27.98%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.91 times
3
Healthy long term growth as Net Sales has grown by an annual rate of 31.50%
4
Flat results in Sep 25
- PAT(Q) At Rs 3.45 cr has Fallen at -22.4% (vs previous 4Q average)
- PBDIT(Q) Lowest at Rs 4.17 cr.
- OPERATING PROFIT TO NET SALES (Q) Lowest at 13.52%
5
With ROCE of 16.4, it has a Very Attractive valuation with a 2.5 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -55.24%, its profits have risen by 43.9% ; the PEG ratio of the company is 0.4
6
Majority shareholders : Promoters
7
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 2.12% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -55.24% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Indo US Bio-Tech should be less than 10%
- Overall Portfolio exposure to Other Agricultural Products should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Indo US Bio-Tech for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Indo US Bio-Tech
-55.24%
-0.84
65.72%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
31.50%
EBIT Growth (5y)
37.70%
EBIT to Interest (avg)
9.15
Debt to EBITDA (avg)
2.09
Net Debt to Equity (avg)
0.31
Sales to Capital Employed (avg)
0.99
Tax Ratio
2.20%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.91%
ROE (avg)
30.09%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
37
Price to Book Value
2.98
EV to EBIT
15.35
EV to EBITDA
14.47
EV to Capital Employed
2.51
EV to Sales
2.41
PEG Ratio
0.35
Dividend Yield
NA
ROCE (Latest)
16.37%
ROE (Latest)
19.48%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
PAT(9M)
At Rs 11.83 cr has Grown at 46.96%
NET SALES(Latest six months)
At Rs 61.62 cr has Grown at 31.41%
-7What is not working for the Company
PAT(Q)
At Rs 3.45 cr has Fallen at -22.4% (vs previous 4Q average
PBDIT(Q)
Lowest at Rs 4.17 cr.
OPERATING PROFIT TO NET SALES (Q)
Lowest at 13.52%
PBT LESS OI(Q)
Lowest at Rs 3.53 cr.
EPS(Q)
Lowest at Rs 1.72
Loading Valuation Snapshot...
Here's what is working for Indo US Bio-Tech
Net Sales - Latest six months
At Rs 61.62 cr has Grown at 31.41%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Indo US Bio-Tech
Profit After Tax (PAT) - Quarterly
At Rs 3.45 cr has Fallen at -22.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 4.45 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 4.17 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at 13.52%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 3.53 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs 1.72
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
